Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2020-05-25 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
2019年年度股东大会会议材料
AGM Information Classification · 100% confidence The document is titled as materials for the 2019 Annual General Meeting (AGM) of 哈药集团股份有限公司, dated June 2, 2020. It contains detailed agenda items typical for an AGM, including the full 2019 Annual Report and its summary, board reports, supervisory board reports, independent directors' reports, audit summary and reappointment of auditors, financial results and budget proposals, profit distribution plans, bank credit applications, shareholder return plans, and amendments to company articles. The document is comprehensive and clearly intended as meeting materials for the AGM, not just an announcement or a brief summary. It includes detailed reports and proposals to be discussed and voted on at the AGM. Therefore, the document fits the category of AGM Information (AGM-R).
2020-05-25 Chinese
关于2019年年度股东大会增加临时提案的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the 2019 Annual General Meeting (AGM) of 哈药集团股份有限公司. It details the date of the AGM, the registration date for shareholders, the nature of the proposals to be voted on, and procedural information about voting. It also includes an authorization letter for proxy voting. The document does not contain the actual annual report or financial statements but rather information about the AGM and its agenda items. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the meeting.
2020-05-21 Chinese
公司章程（2020年5月修订版）
Governance Information Classification · 95% confidence The document is titled "章程" which translates to "Articles of Association" or "Company Bylaws". It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, shareholder meetings, voting procedures, and other governance-related matters. The content is comprehensive and legalistic, focusing on the internal rules and governance framework of the company. There is no indication that this is an annual report, financial statement, earnings release, or any other type of financial or regulatory filing. Instead, it is a governance document that sets out the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-05-21 Chinese
关于修改《公司章程》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the amendment of the company's Articles of Association (公司章程). It details changes to the company's business scope and states that the board of directors has approved the amendments, which still require shareholder approval at the annual general meeting. The document is short (1239 characters) and serves as a formal public notice of these changes rather than the full text of the amended Articles or a detailed report. It does not contain financial statements or detailed management discussion. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about corporate governance changes but not a full governance report or management information filing.
2020-05-21 Chinese
八届三十一次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. It details decisions made at the 31st meeting of the 8th Board of Directors, including approval of amendments to the company's articles of association and submission of a temporary proposal to the 2019 Annual General Meeting. The document is an official announcement of board decisions, not a full report or financial statement. It fits the category of Board/Management Information (MANG) as it relates to board resolutions and governance matters.
2020-05-21 Chinese
八届三十次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. It reports the decision of the board of directors to convene the 2019 Annual General Meeting on June 2, 2020. The document is short (424 characters) and serves as an announcement of a board meeting decision rather than the actual annual report or shareholder meeting materials. It does not contain financial data or detailed report content. Therefore, it fits best under Board/Management Information (MANG) as it relates to board decisions and meeting notices.
2020-05-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.